7
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Nucleotide sequence of exons 5 to 9 of the p53 tumour-suppressor gene of the horse (Equus Caballus)

&
Pages 185-187 | Received 04 Oct 1995, Published online: 11 Jul 2009

References

  • VanDongen J. A., Harris J. R., Peterse J. L., Fentiman IS., Holland R., Salvadori B., Steward H. J. In situ breast cancer: the EORTC Consensus Meeting. 1989, 25–28, lancet
  • Fearon E. R., Vogelstein B. A genetic model for col-orectaf tumorigenesis. Cell 1990; 61: 759–767
  • Hollstein M., Sirdransky, Vogelstein B., Harris CC. p53 mutations in human cancers. Science 1991; 253: 49–53
  • Levine A. J., Momand J., Findtay C. A. The p53 tumour suppressor gene. Nature 1991; 351: 453–456
  • Levine A. J., Chang A., Dittrner D., Notterman D. A., Silver A., Thorn K., Welsh D., Wu M. The p53 tumour suppressor gene. J. Lab Clin Med 1994; 123(6)817–832
  • Nasir L., Reid S. W.J. Nucleotide sequence of exons 5 to 9 of the p53 tumour-suppressor gene of the donkey (Equus asinus). DNA Sequence 1995, In press
  • Shaulsky C, Goldfinger N., Peled A., Rotter V. Involvement of wildtype p53 in pre-B-cell differentiation in vitro. Proc. Natl. Acad. Sci. USA 1991; 88: 8982–8986
  • Shaw P., Bavey R., Tardy S., Sahli R., Sordat B., Costa J. Induction of apoptosis by wildtype p53 in a human colon tumorderived cell line. Proc. Natl. Acad. Sci. USA 1992; 89: 4495–4499

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.